池苗苗,戴飞飞,王亚坤.Her-2表达在食管胃结合部腺癌中的作用研究进展[J].中国肿瘤,2015,24(1):49-52.
Her-2表达在食管胃结合部腺癌中的作用研究进展
Progress of Her-2 Expression in Gastroesophageal Junction Adenocarcinomas
投稿时间:2014-09-17  
DOI:10.11735/j.issn.1004-0242.2015.01.A011
中文关键词:  食管胃结合部腺癌  人类表皮生长因子受体2  综合治疗
英文关键词:gastroesophageal junction adenocarcinomas  human epidermal growth factor receptor 2  comprehensive therapy
基金项目:浙江省自然科学基金(LY13H290013);
作者单位
池苗苗 浙江中医药大学 
戴飞飞 浙江中医药大学 
王亚坤 浙江中医药大学 
摘要点击次数: 2135
全文下载次数: 1130
中文摘要:
      摘 要:近几十年来,食管胃结合部腺癌的发病率正在逐年上升。Her-2表达与食管胃结合部腺癌预后的研究结果呈现争议,研究认为这是因为Her-2检测的局限性和组织标本的异质性而导致不同的结果。对于Her-2过表达的食管胃结合部腺癌,综合治疗包括新辅助放化疗、辅助放化疗、手术治疗及靶向治疗在临床疗效中的地位越来越突出,中医药治疗也在辅助治疗中起到重要作用。
英文摘要:
      Abstract:In recent decades,the incidence of gastroesophageal junction(GEJ)adenocarcinomas is increasing. The relationship between Her-2 expression and prognosis of GEJ adenocarcinomas shows controversy. It leads to different results because of Her-2 detection limitations and tissue heterogeneity. For GEJ adenocarcinomas with Her-2 overexpression,comprehensive therapy including neoadjuvant chemotherapy,adjuvant radiotherapy,surgery and targeted therapy is becoming more and more prominent in the clinic. Traditional Chinese medicine has played an important role in the adjuvant therapy.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器